Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis

[1]  C. D'Orsi.  Breast Imaging Reporting and Data System (BI-RADS) , 2018 .

[2]  W. Berg.  Current Status of Supplemental Screening in Dense Breasts. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Gretchen L. Gierach,et al.  Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities , 2015, Cancer Prevention Research.

[4]  Savannah C Partridge,et al.  Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk? , 2015, Radiology.

[5]  R. Birdwell,et al.  Breast density: clinical implications and assessment methods. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  Jingmei Li,et al.  Digital mammographic density and breast cancer risk: a case–control study of six alternative density assessment methods , 2014, Breast Cancer Research.

[7]  Donald L Weaver,et al.  Comparison of Mammographic Density Assessed as Volumes and Areas among Women Undergoing Diagnostic Image-Guided Breast Biopsy , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[8]  C. Kuhl,et al.  Does MRI Breast “Density” (Degree of Background Enhancement) Correlate With Mammographic Breast Density? , 2014, Journal of magnetic resonance imaging : JMRI.

[9]  C. Vachon,et al.  Mammographic density phenotypes and risk of breast cancer: a meta-analysis. , 2014, Journal of the National Cancer Institute.

[10]  Philippe Valet,et al.  Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. , 2012, Cancer letters.

[11]  Jennifer D. Brooks,et al.  Impact of Tamoxifen on Amount of Fibroglandular Tissue, Background Parenchymal Enhancement, and Cysts on Breast Magnetic Resonance Imaging , 2012, The breast journal.

[12]  Jennifer D. Brooks,et al.  Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. , 2012, Radiology.

[13]  Jennifer D. Brooks,et al.  Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI , 2012, European Radiology.

[14]  W. Noh,et al.  Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. , 2011, European journal of radiology.

[15]  Carla H van Gils,et al.  Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue , 2011, Breast Cancer Research.

[16]  Jinxiang Tan,et al.  Adipocyte is a non-trivial, dynamic partner of breast cancer cells. , 2011, The International journal of developmental biology.

[17]  Jennifer D. Brooks,et al.  Background parenchymal enhancement at breast MR imaging and breast cancer risk. , 2011, Radiology.

[18]  M. Su,et al.  Angiogenesis in the Progression of Breast Ductal Proliferations , 2011, International journal of surgical pathology.

[19]  Karla Kerlikowske,et al.  Volume of Mammographic Density and Risk of Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[20]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[21]  R. Vierkant,et al.  Independent Association of Lobular Involution and Mammographic Breast Density With Breast Cancer Risk , 2010, Journal of the National Cancer Institute.

[22]  P. Valet,et al.  Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? , 2010, Endocrine development.

[23]  V Shane Pankratz,et al.  Association between mammographic density and age-related lobular involution of the breast. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  B. Narin,et al.  Correlation between breast density in mammography and background enhancement in MR mammography , 2010, La radiologia medica.

[25]  S. Cummings,et al.  Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. , 2009, Medical physics.

[26]  S S Cross,et al.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease , 2009, British Journal of Cancer.

[27]  G. Colditz,et al.  Lobule type and subsequent breast cancer risk: Results from the Nurses' Health Studies , 2009, Cancer.

[28]  K. Pavlakis,et al.  The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions , 2008, BMC Cancer.

[29]  Berta M. Geller,et al.  Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women , 2007, Breast Cancer Research and Treatment.

[30]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[31]  D. Vanel.  The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language? , 2007, European journal of radiology.

[32]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[33]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[34]  J. Skelly,et al.  Predicting Biopsy Outcome After Mammography: What Is the Likelihood the Patient Has Invasive or In Situ Breast Cancer? , 2005, Annals of Surgical Oncology.

[35]  G. Bevilacqua,et al.  Angiogenesis and VEGF expression in pre‐invasive lesions of the human breast , 2004, The Journal of pathology.

[36]  L. Liberman,et al.  Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.

[37]  J. Bahi,et al.  Angiogenesis and risk of breast cancer in women with fibrocystic disease. , 1994, Journal of the National Cancer Institute.

[38]  R. Billingham,et al.  ADIPOSE TISSUE, A NEGLECTED FACTOR IN ÆTIOLOGY OF BREAST CANCER? , 1978, The Lancet.

[39]  H. Bush,et al.  Breast Cancer Research , 1978, British Journal of Cancer.

[40]  Dollery Ct,et al.  SPINA BIFIDA CYSTICA. , 1964, Lancet.

[41]  Elizabeth A Morris,et al.  Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. , 2011, AJR. American journal of roentgenology.

[42]  N. Weidner,et al.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors , 2004, Breast Cancer Research and Treatment.